A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy

por Jang, Mihue, Han, Hee Dong, Ahn, Hyung Jun
Publicado 2016

A T7 autogene-based hybrid mRNA/DNA system for long-term shRNA expression in cytoplasm without inefficient nuclear entry

por Kwak, Seo Young, Han, Hee Dong, Ahn, Hyung Jun
Publicado 2019

PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer

por Risnayanti, Chitra, Jang, Yeong-Su, Lee, Jinju, Ahn, Hyung Jun
Publicado 2018

Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription

por Jang, Mihue, Kim, Jong Hwan, Nam, Hae Yun, Kwon, Ick Chan, Ahn, Hyung Jun
Publicado 2015

Field Investigation of Clay Balls in Full-Depth Asphalt Pavement

por Zhang, Weiguang, Lee, Jusang, Ahn, Hyung Jun, Le, Qiqi, Wu, Meng, Zhu, Haoran, Zhang, Jing
Publicado 2019

The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis

por Hwang, Jae Ryoung, Cho, Young-Jae, Lee, Yoonna, Park, Youngmee, Han, Hee Dong, Ahn, Hyung Jun, Lee, Je-Ho, Lee, Jeong-Won
Publicado 2016

siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

por Jung, Jae Yun, Ryu, Hyun Jin, Lee, Seung-Hwan, Kim, Dong-Young, Kim, Myung Ji, Lee, Eun Ji, Ryu, Yeon-Mi, Kim, Sang-Yeob, Kim, Kyu-Pyo, Choi, Eun Young, Ahn, Hyung Jun, Chang, Suhwan
Publicado 2021

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer

por Kim, Ga Hee, Won, Ji Eun, Byeon, Yeongseon, Kim, Min Gi, Wi, Tae In, Lee, Jae Myeong, Park, Yun-Yong, Lee, Jeong-Won, Kang, Tae Heung, Jung, In Duk, Shin, Byung Cheol, Ahn, Hyung Jun, Lee, Young Joo, Sood, Anil K., Han, Hee Dong, Park, Yeong-Min
Publicado 2018

In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy

por Han, Hee Dong, Byeon, Yeongseon, Jang, Jong-Hwa, Jeon, Hat Nim, Kim, Ga Hee, Kim, Min Gi, Pack, Chan-Gi, Kang, Tae Heung, Jung, In Duk, Lim, Yong Taik, Lee, Young Joo, Lee, Jeong-Won, Shin, Byung Cheol, Ahn, Hyung Jun, Sood, Anil K., Park, Yeong-Min
Publicado 2016

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer

por Paik, E Sun, Kim, Tae-Hyun, Cho, Young Jae, Ryu, Jiyoon, Choi, Jung-Joo, Lee, Yoo-Young, Kim, Tae-Joong, Choi, Chel-Hun, Kim, Woo Young, Sa, Jason K., Lee, Jin-Ku, Kim, Byoung-Gie, Bae, Duk-Soo, Han, Hee Dong, Ahn, Hyung Jun, Lee, Jeong-Won
Publicado 2020

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

por Sa, Jason K., Hwang, Jae Ryoung, Cho, Young-Jae, Ryu, Ji-Yoon, Choi, Jung-Joo, Jeong, Soo Young, Kim, Jihye, Kim, Myeong Seon, Paik, E. Sun, Lee, Yoo-Young, Choi, Chel Hun, Kim, Tae-Joong, Kim, Byoung-Gie, Bae, Duk-Soo, Lee, Yeri, Her, Nam-Gu, Shin, Yong Jae, Cho, Hee Jin, Kim, Ja Yeon, Seo, Yun Jee, Koo, Harim, Oh, Jeong-Woo, Lee, Taebum, Kim, Hyun-Soo, Song, Sang Yong, Bae, Joon Seol, Park, Woong-Yang, Han, Hee Dong, Ahn, Hyung Jun, Sood, Anil K., Rabadan, Raul, Lee, Jin-Ku, Nam, Do-Hyun, Lee, Jeong-Won
Publicado 2019